pistacia lentiscus oil efficacy in the treatment of women with fibrocystic breast disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260201068718N1

Enrollment

Registered

2026-02-04

Start date

2026-02-07

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fibrocystic breast disease. Diffuse cystic mastopathy of unspecified breast

Interventions

Intervention group: A patient with fibrocystic breast disease who applied mastic oil to the area every night for forty nights and covered it with cellophane.

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with fibrocystic disease based on ultrasound pain

Exclusion criteria

Exclusion criteria: cancer of breast breast surgery sensitivity to herbal medicine

Design outcomes

Primary

Measure	Time frame
Size of breast cyst. Timepoint: before and after 40 days after treatment. Method of measurement: ultrasonography.	—

Secondary

Measure	Time frame
Pain. Timepoint: before and after 40 days of treatment. Method of measurement: VAS score for pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthajar khazraei

Shiraz University of Medical Sciences

hajarkhazraei@gmail.com+98 71 3628 1453

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026